Literature DB >> 21453387

Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma.

Yoshihiro Komohara1, Horlad Hasita, Koji Ohnishi, Yukio Fujiwara, Shinya Suzu, Masatoshi Eto, Motohiro Takeya.   

Abstract

Most malignant tumors evidence infiltration of many macrophages. In this study, we investigated an anti-inflammatory macrophage phenotype (M2) in clear cell renal cell carcinoma (RCC) using CD163 and CD204 as markers. Immunostaining showed a correlation between the number of CD163(+) cells and age, sex, nuclear grade, and TNM classification. High infiltration of CD163(+) cells was significantly associated with poor clinical prognosis in univariate analysis but not in multivariate analysis. We also carried out in vitro studies to examine cell-cell interactions between macrophages and cancer cells. Culture supernatants from RCC cell lines induced polarization of macrophages toward the M2 phenotype. Coculture of macrophages with cancer cells significantly induced activation of signal transducers and activators of transcription-3 (Stat3) in the cancer cells. Direct coculture of RCC cells with macrophages led to stronger activation of Stat3 in the cancer cells than did indirect coculture using Transwell chamber dishes. Because RCC cells expressed membrane-type macrophage colony-stimulating factor (mM-CSF) on the cell surface, we suggested that this mM-CSF plays an important role in direct cell-cell interactions. Stat3 activation in cancer cells that was induced by coculture with macrophages was suppressed by downregulation of the M-CSF receptor (M-CSFR) in macrophages and by an inhibitor of M-CSFR. In conclusion, investigation of CD163(+) tumor-associated macrophages would be useful for assessment of the clinical prognosis of patients with ccRCC. Cell-cell interactions mediated by mM-CSF and M-CSFR binding could contribute to cancer cell activation.
© 2011 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21453387     DOI: 10.1111/j.1349-7006.2011.01945.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  95 in total

Review 1.  The secret ally: immunostimulation by anticancer drugs.

Authors:  Lorenzo Galluzzi; Laura Senovilla; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Rev Drug Discov       Date:  2012-02-03       Impact factor: 84.694

Review 2.  Immunological heterogeneity of the RCC microenvironment: do targeted therapies influence immune response?

Authors:  Axel Bex; Tamara Etto; Florry Vyth-Dreese; Christian Blank; Arjan W Griffioen
Journal:  Curr Oncol Rep       Date:  2012-06       Impact factor: 5.075

3.  Identification of prognostic immunophenotypic features in cancer stromal cells of high-grade neuroendocrine carcinomas of the lung.

Authors:  Akiko Takahashi; Genichiro Ishii; Tomonari Kinoshita; Tatsuya Yoshida; Shigeki Umemura; Tomoyuki Hishida; Kiyotaka Yoh; Seiji Niho; Koichi Goto; Hironobu Ohmatsu; Yuichiro Ohe; Kanji Nagai; Atsushi Ochiai
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-07       Impact factor: 4.553

4.  Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors.

Authors:  Sergey V Ryzhov; Michael W Pickup; Anna Chytil; Agnieszka E Gorska; Qinkun Zhang; Philip Owens; Igor Feoktistov; Harold L Moses; Sergey V Novitskiy
Journal:  J Immunol       Date:  2014-08-15       Impact factor: 5.422

5.  Autocrine CSF-1 and CSF-1 receptor coexpression promotes renal cell carcinoma growth.

Authors:  Julia Menke; Jörg Kriegsmann; Carl Christoph Schimanski; Melvin M Schwartz; Andreas Schwarting; Vicki R Kelley
Journal:  Cancer Res       Date:  2011-11-03       Impact factor: 12.701

6.  Phenotypical change of tumor-associated macrophages in metastatic lesions of clear cell renal cell carcinoma.

Authors:  Takanobu Motoshima; Yuji Miura; Nanako Wakigami; Natsuki Kusada; Toshimi Takano; Naoko Inoshita; Toshikazu Okaneya; Yutaka Sugiyama; Tomomi Kamba; Motohiro Takeya; Yoshihiro Komohara
Journal:  Med Mol Morphol       Date:  2017-12-07       Impact factor: 2.309

7.  Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma.

Authors:  Carl Ludwig Behnes; Felix Bremmer; Bernhard Hemmerlein; Arne Strauss; Philipp Ströbel; Heinz-Joachim Radzun
Journal:  Virchows Arch       Date:  2013-12-11       Impact factor: 4.064

8.  Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy.

Authors:  Christel Devaud; Jennifer A Westwood; Liza B John; Jacqueline K Flynn; Sophie Paquet-Fifield; Connie P M Duong; Carmen S M Yong; Hollie J Pegram; Steven A Stacker; Marc G Achen; Trina J Stewart; Linda A Snyder; Michele W L Teng; Mark J Smyth; Phillip K Darcy; Michael H Kershaw
Journal:  Mol Ther       Date:  2013-09-19       Impact factor: 11.454

9.  Epidermal growth factor (EGF)-enhanced vascular cell adhesion molecule-1 (VCAM-1) expression promotes macrophage and glioblastoma cell interaction and tumor cell invasion.

Authors:  Yanhua Zheng; Weiwei Yang; Kenneth Aldape; Jie He; Zhimin Lu
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

Review 10.  Modification of the tumor microenvironment as a novel target of renal cell carcinoma therapeutics.

Authors:  James H Finke; Pat A Rayman; Jennifer S Ko; Judy M Bradley; Sandra J Gendler; Peter A Cohen
Journal:  Cancer J       Date:  2013 Jul-Aug       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.